Yeo W - Search Results

1

A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma.

Chan SL, Cheng PNM, Liu AM, Chan LL, Li L, Chu CM, Chong CCN, Lau YM, Yeo W, Ng KKC, Yu SCH, Mok TSK, Chan AWH. Chan SL, et al. Among authors: yeo w. Invest New Drugs. 2021 Oct;39(5):1375-1382. doi: 10.1007/s10637-021-01111-8. Epub 2021 Apr 15. Invest New Drugs. 2021. PMID: 33856599 Free PMC article. Clinical Trial.

2

Extraosseous osteogenic sarcoma of the mediastinum occurring in a Chinese patient.

Lin J, Ho J, Chan A, Yeo W, Yip KM, Johnson PJ. Lin J, et al. Among authors: yeo w. Clin Oncol (R Coll Radiol). 1995;7(3):200-1. doi: 10.1016/s0936-6555(05)80518-7. Clin Oncol (R Coll Radiol). 1995. PMID: 7547527 Review.

3

Isoelectric focusing of alphafetoprotein in patients with hepatocellular carcinoma--frequency of specific banding patterns at non-diagnostic serum levels.

Ho S, Cheng P, Yuen J, Chan A, Leung N, Yeo W, Leung T, Lau WY, Li AK, Johnson PJ. Ho S, et al. Among authors: yeo w. Br J Cancer. 1996 Apr;73(8):985-8. doi: 10.1038/bjc.1996.192. Br J Cancer. 1996. PMID: 8611436 Free PMC article.

4

Nasal lymphoma: results of local radiotherapy with or without chemotherapy.

Yu KH, Yu SC, Teo PM, Chan AT, Yeo W, Chow J. Yu KH, et al. Among authors: yeo w. Head Neck. 1997 Jul;19(4):251-9. doi: 10.1002/(sici)1097-0347(199707)19:4<251::aid-hed2>3.0.co;2-#. Head Neck. 1997. PMID: 9213102

5

Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma.

Mok TS, Steinberg J, Chan AT, Yeo WM, Hui P, Leung TW, Johnson P. Mok TS, et al. Among authors: yeo wm. Cancer. 1998 Jun 15;82(12):2439-48. doi: 10.1002/(sici)1097-0142(19980615)82:12<2439::aid-cncr19>3.0.co;2-q. Cancer. 1998. PMID: 9635538

6

Phase II study of Temodal in the treatment of patients with advanced nasopharyngeal carcinoma.

Chan AT, Leung TW, Kwan WH, Mok TS, Yeo W, Lai M, Johnson PJ. Chan AT, et al. Among authors: yeo w. Cancer Chemother Pharmacol. 1998;42(3):247-9. doi: 10.1007/s002800050812. Cancer Chemother Pharmacol. 1998. PMID: 9685061 Clinical Trial.

7

A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma.

Yeo W, Leung TW, Chan AT, Chiu SK, Yu P, Mok TS, Johnson PJ. Yeo W, et al. Eur J Cancer. 1998 Dec;34(13):2027-31. doi: 10.1016/s0959-8049(98)00280-9. Eur J Cancer. 1998. PMID: 10070305 Clinical Trial.

8

Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma.

Leung TW, Patt YZ, Lau WY, Ho SK, Yu SC, Chan AT, Mok TS, Yeo W, Liew CT, Leung NW, Tang AM, Johnson PJ. Leung TW, et al. Among authors: yeo w. Clin Cancer Res. 1999 Jul;5(7):1676-81. Clin Cancer Res. 1999. PMID: 10430068 Clinical Trial.

9

A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma.

Mok TS, Leung TW, Lee SD, Chao Y, Chan AT, Huang A, Lui MC, Yeo W, Chak K, Johnston A, Johnson P. Mok TS, et al. Among authors: yeo w. Cancer Chemother Pharmacol. 1999;44(4):307-11. doi: 10.1007/s002800050982. Cancer Chemother Pharmacol. 1999. PMID: 10447578 Clinical Trial.

10

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.

Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J, Chan AT, Yeo W, Mok TS, Yu SC, Leung NW, Johnson PJ. Lau WY, et al. Among authors: yeo w. Lancet. 1999 Mar 6;353(9155):797-801. doi: 10.1016/s0140-6736(98)06475-7. Lancet. 1999. PMID: 10459961 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

919 results

Search Page

Filters